Joseph Patrick McEvoy


  • 23718 Citations
  • 75 h-Index
1978 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Schizophrenia Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
olanzapine Medicine & Life Sciences
Psychotic Disorders Medicine & Life Sciences
Risperidone Medicine & Life Sciences
Haloperidol Medicine & Life Sciences
Clozapine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2018

Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 othersBuckley, P. F., Rachbeisel, J. A. & McEvoy, J. P., Aug 1 2018, In : Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.

Research output: Contribution to journalArticle

Psychotic Disorders
Clinical Trials
2 Citations

Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels

Wehring, H. J., Elsobky, T., McEvoy, J. P., Vyas, G., Richardson, C. M., McMahon, R. P., DiPaula, B. A., Liu, F., Sullivan, K., Buchanan, R. W., Feldman, S., McMahon, E. M. & Kelly, D. L., Mar 1 2018, In : Psychiatric Quarterly. 89, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP1A2
Clinical Trials, Phase I

Revisiting the abnormal involuntary movement scale: Proceedings from the tardive dyskinesia assessment workshop

Kane, J. M., Correll, C. U., Nierenberg, A. A., Caroff, S. N., Sajatovic, M., Cutler, A. J., McEvoy, J. P. & Stacy, M., May 1 2018, In : Journal of Clinical Psychiatry. 79, 3, 17cs11959.

Research output: Contribution to journalArticle

Clinical Trials
Tardive Dyskinesia
Abnormal Involuntary Movement Scale
36 Citations

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

Anderson, K. E., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Isojärvi, J., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., McEvoy, J. P., Ochudlo, S., Ondo, W. G. & Fernandez, H. H., Aug 1 2017, In : The Lancet Psychiatry. 4, 8, p. 595-604 10 p.

Research output: Contribution to journalArticle

Dopamine Antagonists
Patient Safety